NPC

Clinical trials for NPC explained in plain language.

Never miss a new study

Get alerted when new NPC trials appear

Sign up with your email to follow new studies for NPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New Two-Drug attack on advanced throat cancer begins testing

Disease control Not yet recruiting

This study is testing whether adding two immunotherapy drugs (pembrolizumab and MRG-003) before and after standard chemoradiation can better control advanced nasopharyngeal cancer. It will involve about 35 adults with a specific type of this cancer linked to the Epstein-Barr viru…

Matched conditions: NPC

Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

NPC

Get alerted when new NPC trials appear

New Two-Drug attack on advanced throat cancer begins testing